Public health implications of legalising the production and sale of cannabis for medicinal and recreational use

W Hall, D Stjepanović, J Caulkins, M Lynskey, J Leung… - The Lancet, 2019 - thelancet.com
We assess the current and describe possible future public health impacts of the legalisation
of cannabis production, sale, and use in the Americas. First, we describe global patterns of …

Keep off the grass? Cannabis, cognition and addiction

HV Curran, TP Freeman, C Mokrysz… - Nature Reviews …, 2016 - nature.com
In an increasing number of states and countries, cannabis now stands poised to join alcohol
and tobacco as a legal drug. Quantifying the relative adverse and beneficial effects of …

Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013

DS Hasin, TD Saha, BT Kerridge, RB Goldstein… - JAMA …, 2015 - jamanetwork.com
Importance Laws and attitudes toward marijuana in the United States are becoming more
permissive but little is known about whether the prevalence rates of marijuana use and …

Prevalence and correlates of DSM-5 cannabis use disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions–III

DS Hasin, BT Kerridge, TD Saha… - American Journal of …, 2016 - Am Psychiatric Assoc
Objective: Attitudes toward marijuana are changing, the prevalence of DSM-IV cannabis use
disorder has increased, and DSM-5 modified the cannabis use disorder criteria. Therefore …

US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws: 1991-1992 to 2012-2013

DS Hasin, AL Sarvet, M Cerdá, KM Keyes… - JAMA …, 2017 - jamanetwork.com
Importance Over the last 25 years, illicit cannabis use and cannabis use disorders have
increased among US adults, and 28 states have passed medical marijuana laws (MML) …

Psychosocial interventions for cannabis use disorder

PJ Gates, P Sabioni, J Copeland… - … of systematic reviews, 2016 - cochranelibrary.com
Background Cannabis use disorder is the most commonly reported illegal substance use
disorder in the general population; although demand for assistance from health services is …

Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys

L Degenhardt, M Glantz, S Evans‐Lacko… - World …, 2017 - Wiley Online Library
Substance use is a major cause of disability globally. This has been recognized in the recent
United Nations Sustainable Development Goals (SDGs), in which treatment coverage for …

Prevalence of cannabis withdrawal symptoms among people with regular or dependent use of cannabinoids: a systematic review and meta-analysis

A Bahji, C Stephenson, R Tyo, ER Hawken… - JAMA network …, 2020 - jamanetwork.com
Importance Cannabis withdrawal syndrome (CWS)—a diagnostic indicator of cannabis use
disorder—commonly occurs on cessation of heavy and prolonged cannabis use. To date …

Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use

EP Calandre, F Rico-Villademoros… - Expert review of …, 2016 - Taylor & Francis
Introduction: The first two alpha2delta ligands–gabapentin (GBP) and pregabalin (PGB)–
were initially synthesized as antiepileptics; however, they were later also found to be useful …

Treatment of cannabis use disorder: current science and future outlook

BJ Sherman, AL McRae‐Clark - Pharmacotherapy: The Journal …, 2016 - Wiley Online Library
Cannabis is the most commonly used illicit substance in the United States. Rates of
cannabis use and cannabis use disorder (CUD) have increased in the past decade …